Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-04-19
2011-04-19
Davis, Zinna N (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S148000
Reexamination Certificate
active
07928121
ABSTRACT:
The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some tetrahydroisoquinoline substituted sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.
REFERENCES:
patent: 0 021 580 (1983-12-01), None
patent: 0 076 072 (1987-05-01), None
patent: WO 97/29097 (1997-08-01), None
patent: WO 97/48681 (1997-12-01), None
patent: WO 97/49695 (1997-12-01), None
patent: WO 99/24022 (1999-05-01), None
patent: WO 00/00472 (2000-01-01), None
patent: WO 03/048118 (2003-06-01), None
West, Anthony R., Solid State Chemistry and its Applications, Wiley, New York, 1988, pp. 358 & 365.
Wu et al., Toxicology, 236, pp. 1-6, 2007.
Terron, J. A., IDrugs, vol. 1(3), pp. 302-301, 1998.
Lovenberg. et al., Neuron, vol. 11, pp. 449-458, 1993.
Terron, J. A., Br. J. Phaimacol., vol. 121, pp. 563-571, 1997.
Schoeffter et al., Br. J. Pharmacol., vol. 117, pp. 993-997, 1996.
Terron, J. A., Eur. J. Pharmacol., vol. 439, pp. 1-11, 2002.
De Ponti et al., Drugs, vol. 61, pp. 317-332, 2001.
Read et al., Br. J. Pharmacol., vol. 140, pp. 53-60, Jul. 29, 2003.
Wesolowska, A., Polish J. Pharmacol., vol. 54, pp. 327-341, 2002.
Whaley, Organic Reactions, vol. 6 (chapter 3), pp. 151-190, 1951.
Munson et al., Anal. Biochem., vol. 107, pp. 220-239, 1980.
Vermeulen et al., J. Med. Chem., vol. 47, pp. 5451-5466, Sep. 23, 2004.
European Patent Office, European Search Report for EP 04380279.2, issued May 23, 2005.
PCT International Search Report, PCT/EP2005/014046, dated Feb. 24, 2006.
Alonso Luz Romero
Buschmann Helmut Henrich
Dordal Zueras Alberto
Jover Antoni Torrens
Mas Prió Josep
Davis Zinna N
Laboratorios Del Dr. Esteve, S.A.
Locke Lord Bissell & Liddell LLP
LandOfFree
5-HT7 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-HT7 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-HT7 receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2656425